These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment. Rahman SA, Jha P, Laumas V, Jain AK, Dileepkumar, Takkar D, Hingorani V, Laumas KR. Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011 [Abstract] [Full Text] [Related]
3. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone. Goebelsmann U, Stanczyk FZ, Brenner PF, Goebelsmann AE, Gentzschein EK, Mishell DR. Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279 [Abstract] [Full Text] [Related]
9. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation. Letterie GS. Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249 [Abstract] [Full Text] [Related]
10. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol. Weisberg E, Fraser IS, Mishell DR, Lacarra M, Darney P, Jackanicz TM. Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484 [Abstract] [Full Text] [Related]
11. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception. Balogh A, Ditrói F, Lampé LG. Acta Univ Palacki Olomuc Fac Med; 1981 May; 101():95-101. PubMed ID: 6242699 [Abstract] [Full Text] [Related]
12. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use. Xiao B, Zeng T, Wu S, Sun H, Xiao N. Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977 [Abstract] [Full Text] [Related]
15. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat. Welschen R, Osman P, Dullaart J, de Greef WJ, Uilenbroek JT, de Jong FH. J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896 [Abstract] [Full Text] [Related]
17. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology. Niaraki MA, Moghissi KS, Borin K. Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938 [Abstract] [Full Text] [Related]
18. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Moutos D, Smith S, Zacur H. Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446 [Abstract] [Full Text] [Related]
19. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins. McGuire JL, Bariso CD, Yuliano E, Hume RJ, Pasquale SA. Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369 [Abstract] [Full Text] [Related]
20. The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis. Nuttall ID, Elstein M, Fahmy DR. Contraception; 1982 May; 25(5):463-9. PubMed ID: 6809424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]